• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管主动脉瓣置换术后患者心脏淀粉样变性的转诊:质量成果项目的结果

Referral for Cardiac Amyloidosis in Patients Who Underwent Transcatheter Aortic Valve Replacement: Results of the Quality Outcome Project.

作者信息

Lee Dae Hyun, Eichelberger Gerry S, Patel Vandan, Chhaya Ronak, Khadilkar Arjun, Bishop Jennifer, Bezerra Hiram, Oliveira Guilherme, Matar Fadi, Fernandez Joel

机构信息

Department of Cardiovascular Medicine, University of South Florida, Tampa, USA.

Department of Internal Medicine, University of South Florida, Tampa, USA.

出版信息

Cureus. 2023 Sep 11;15(9):e45024. doi: 10.7759/cureus.45024. eCollection 2023 Sep.

DOI:10.7759/cureus.45024
PMID:37829941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10566222/
Abstract

Background Transthyretin cardiac amyloidosis (ATTR) is an important comorbidity present in severe aortic stenosis (AS). The purpose of this study was to raise awareness of ATTR in patients who underwent transcatheter aortic valve replacement (TAVR) for severe AS among healthcare providers and patients. Methodology We reviewed 197 consecutive TAVR cases performed from 2019 to 2020. Adapting predefined high-risk features for ATTR based on prior literature, we contacted the patients to discuss our clinical suspicion of ATTR and offered a referral to a cardiac amyloid specialist. Results We identified 125 (69.4%) patients who had high-risk features of ATTR. Of the 105 patients contacted, 44 patients agreed to referral, 46 patients were not able to be contacted after several attempts, and 15 patients declined referral. Of the 44 patients who agreed to the referral, 20 patients completed the evaluation for cardiac amyloidosis, all of whom were negative for transthyretin and light-chain cardiac amyloidosis. Conclusions Our attempt to detect ATTR in prior TAVR patients was unsuccessful two to three years post-TAVR. We believe that early detection of cardiac amyloidosis close to the timing of TAVR is important and the most effective means.

摘要

背景

转甲状腺素蛋白心脏淀粉样变性(ATTR)是严重主动脉瓣狭窄(AS)中存在的一种重要合并症。本研究的目的是提高医疗服务提供者和患者对重度AS患者经导管主动脉瓣置换术(TAVR)后ATTR的认识。方法:我们回顾了2019年至2020年连续进行的197例TAVR病例。根据先前文献改编了针对ATTR的预定义高危特征,我们联系患者以讨论我们对ATTR的临床怀疑,并提供转介至心脏淀粉样变性专家的服务。结果:我们确定了125例(69.4%)具有ATTR高危特征的患者。在联系的105例患者中,44例患者同意转介,46例患者经多次尝试后无法联系到,15例患者拒绝转介。在同意转介的44例患者中,20例患者完成了心脏淀粉样变性评估,所有患者转甲状腺素蛋白和轻链心脏淀粉样变性均为阴性。结论:我们在TAVR术后两到三年检测既往TAVR患者ATTR的尝试未成功。我们认为在接近TAVR时机时早期检测心脏淀粉样变性很重要且是最有效的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fdf/10566222/f66ad50a80d0/cureus-0015-00000045024-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fdf/10566222/f66ad50a80d0/cureus-0015-00000045024-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fdf/10566222/f66ad50a80d0/cureus-0015-00000045024-i01.jpg

相似文献

1
Referral for Cardiac Amyloidosis in Patients Who Underwent Transcatheter Aortic Valve Replacement: Results of the Quality Outcome Project.经导管主动脉瓣置换术后患者心脏淀粉样变性的转诊:质量成果项目的结果
Cureus. 2023 Sep 11;15(9):e45024. doi: 10.7759/cureus.45024. eCollection 2023 Sep.
2
Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population: A Pilot Study.印度老年人群中伴发甲状腺素运载蛋白淀粉样变与严重主动脉瓣狭窄:一项初步研究
JACC CardioOncol. 2021 Oct 19;3(4):565-576. doi: 10.1016/j.jaccao.2021.08.008. eCollection 2021 Oct.
3
Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis.揭示并存严重主动脉瓣狭窄和转甲状腺素蛋白心脏淀粉样变性的结果。
Eur J Heart Fail. 2021 Feb;23(2):250-258. doi: 10.1002/ejhf.1974. Epub 2020 Sep 8.
4
Transthyretin cardiac amyloidosis in patients after TAVR: clinical and echocardiographic findings and long term survival.经导管主动脉瓣置换术后患者的转甲状腺素蛋白心脏淀粉样变性:临床和超声心动图表现及长期生存。
ESC Heart Fail. 2021 Dec;8(6):4549-4561. doi: 10.1002/ehf2.13667. Epub 2021 Oct 26.
5
Transthyretin cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: experience of a single center.严重主动脉瓣狭窄患者经导管主动脉瓣置换术中的转甲状腺素蛋白心脏淀粉样变性:单中心经验
Minerva Cardiol Angiol. 2024 Feb;72(1):87-94. doi: 10.23736/S2724-5683.23.06175-6. Epub 2023 Jul 5.
6
Prevalence of ATTR-CA and high-risk features to guide testing in patients referred for TAVR.ATTR-CA 的患病率和高危特征,以指导接受 TAVR 转诊患者的检测。
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):3910-3916. doi: 10.1007/s00259-023-06374-2. Epub 2023 Aug 22.
7
Reverse Remodeling Following Valve Replacement in Coexisting Aortic Stenosis and Transthyretin Cardiac Amyloidosis.心脏转流瓣膜置换术后并存主动脉瓣狭窄和甲状腺素运载蛋白心脏淀粉样变性的逆向重构。
Circ Cardiovasc Imaging. 2022 Jul;15(7):e014115. doi: 10.1161/CIRCIMAGING.122.014115. Epub 2022 Jul 8.
8
ATTR Amyloidosis: Current and Emerging Management Strategies: State-of-the-Art Review.转甲状腺素蛋白淀粉样变性:当前及新出现的管理策略:最新综述
JACC CardioOncol. 2021 Oct 19;3(4):488-505. doi: 10.1016/j.jaccao.2021.06.006. eCollection 2021 Oct.
9
Amyloid Transthyretin Cardiomyopathy in Elderly Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation.老年主动脉瓣狭窄行经导管主动脉瓣置换术患者的转甲状腺素蛋白淀粉样变心肌病。
J Am Heart Assoc. 2023 Aug 15;12(16):e030271. doi: 10.1161/JAHA.123.030271. Epub 2023 Aug 10.
10
Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis.经导管主动脉瓣置换术在主动脉瓣狭窄和心脏淀粉样变性中的应用:系统评价和荟萃分析。
ESC Heart Fail. 2022 Oct;9(5):3188-3197. doi: 10.1002/ehf2.13876. Epub 2022 Jun 29.

本文引用的文献

1
Targeted Screening for Transthyretin Amyloid Cardiomyopathy in Patients With Atrial Fibrillation.
Circulation. 2022 Nov 29;146(22):1730-1732. doi: 10.1161/CIRCULATIONAHA.122.060596. Epub 2022 Nov 28.
2
Prevalence and outcomes of concomitant cardiac amyloidosis and aortic stenosis: A systematic review and meta-analysis.同时患有心脏淀粉样变性和主动脉瓣狭窄的患病率和结局:系统评价和荟萃分析。
Hellenic J Cardiol. 2022 Mar-Apr;64:67-76. doi: 10.1016/j.hjc.2021.11.001. Epub 2021 Nov 29.
3
Incremental Value of Global Longitudinal Strain for Predicting Survival in Patients With Advanced AL Amyloidosis.整体纵向应变对预测晚期轻链型淀粉样变患者生存率的增量价值
JACC CardioOncol. 2020 Jun;2(2):223-231. doi: 10.1016/j.jaccao.2020.05.012. Epub 2020 Jun 16.
4
Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation.接受经导管主动脉瓣植入术患者的双主动脉瓣狭窄与心脏淀粉样变病理的患病率及预后
Eur Heart J. 2020 Aug 1;41(29):2759-2767. doi: 10.1093/eurheartj/ehaa170.
5
Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week.主动脉瓣狭窄与心脏淀粉样变性:美国心脏病学会评论专题周报
J Am Coll Cardiol. 2019 Nov 26;74(21):2638-2651. doi: 10.1016/j.jacc.2019.09.056.
6
How to Image Cardiac Amyloidosis: A Practical Approach.如何成像心脏淀粉样变性:实用方法。
JACC Cardiovasc Imaging. 2020 Jun;13(6):1368-1383. doi: 10.1016/j.jcmg.2019.07.015. Epub 2019 Oct 11.
7
Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.转甲状腺素蛋白淀粉样心肌病:美国心脏病学会最新临床综述
J Am Coll Cardiol. 2019 Jun 11;73(22):2872-2891. doi: 10.1016/j.jacc.2019.04.003.
8
The REDCap consortium: Building an international community of software platform partners.REDCap 联盟:构建软件平台合作伙伴的国际社区。
J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9.
9
Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release.腕管松解术患者的腱鞘炎和心脏淀粉样变性。
J Am Coll Cardiol. 2018 Oct 23;72(17):2040-2050. doi: 10.1016/j.jacc.2018.07.092.
10
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.特发性甲状腺素运载蛋白淀粉样变心肌病患者的塔法米迪治疗。
N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27.